BCWORLD PHARM. CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,080 KRW | -1.30% |
|
-1.78% | -5.88% |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 172,278 | 121,692 | 201,510 | 135,336 | 71,475 | 54,513 |
| Enterprise Value (EV) 1 | 217,039 | 176,123 | 265,288 | 219,855 | 157,672 | 135,188 |
| P/E ratio | 34.5 x | -78.5 x | -127 x | -91.5 x | 257 x | 20.7 x |
| Yield | 0.45% | 0.63% | 0.42% | 0.63% | 1.18% | 1.55% |
| Capitalization / Revenue | 3.14 x | 2.36 x | 3.53 x | 2.18 x | 0.98 x | 0.73 x |
| EV / Revenue | 3.96 x | 3.42 x | 4.65 x | 3.54 x | 2.17 x | 1.8 x |
| EV / EBITDA | 24.4 x | 66.4 x | 107 x | 60.1 x | 17.4 x | 9.77 x |
| EV / FCF | -15.5 x | -11.7 x | -22.6 x | -3.54 x | -63.2 x | 25.9 x |
| FCF Yield | -6.44% | -8.51% | -4.43% | -28.3% | -1.58% | 3.86% |
| Price to Book | 1.99 x | 1.42 x | 2.39 x | 1.65 x | 0.9 x | 0.67 x |
| Nbr of stocks (in thousands) | 8,460 | 8,422 | 8,539 | 8,539 | 8,439 | 8,439 |
| Reference price 2 | 20,364 | 14,450 | 23,600 | 15,850 | 8,470 | 6,460 |
| Announcement Date | 07/03/19 | 06/03/20 | 24/02/21 | 10/03/22 | 22/03/23 | 11/03/24 |
1KRW in Million2KRW
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 54,792 | 51,497 | 57,030 | 62,079 | 72,703 | 75,111 |
| EBITDA 1 | 8,909 | 2,654 | 2,473 | 3,655 | 9,070 | 13,835 |
| EBIT 1 | 5,601 | -1,005 | -2,096 | -1,798 | 1,862 | 6,365 |
| Operating Margin | 10.22% | -1.95% | -3.68% | -2.9% | 2.56% | 8.47% |
| Earnings before Tax (EBT) 1 | 5,487 | -2,572 | -2,830 | -2,000 | -1,523 | 1,206 |
| Net income 1 | 4,993 | -1,553 | -1,580 | -1,478 | 281.3 | 2,634 |
| Net margin | 9.11% | -3.02% | -2.77% | -2.38% | 0.39% | 3.51% |
| EPS 2 | 590.2 | -184.0 | -185.7 | -173.1 | 33.01 | 312.1 |
| Free Cash Flow 1 | -13,968 | -14,992 | -11,755 | -62,122 | -2,496 | 5,224 |
| FCF margin | -25.49% | -29.11% | -20.61% | -100.07% | -3.43% | 6.95% |
| FCF Conversion (EBITDA) | - | - | - | - | - | 37.76% |
| FCF Conversion (Net income) | - | - | - | - | - | 198.34% |
| Dividend per Share 2 | 90.91 | 90.91 | 100.0 | 100.0 | 100.0 | 100.0 |
| Announcement Date | 07/03/19 | 06/03/20 | 24/02/21 | 10/03/22 | 22/03/23 | 11/03/24 |
1KRW in Million2KRW
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 44,760 | 54,431 | 63,777 | 84,518 | 86,197 | 80,675 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 5.024 x | 20.51 x | 25.79 x | 23.12 x | 9.503 x | 5.831 x |
| Free Cash Flow 1 | -13,968 | -14,992 | -11,755 | -62,122 | -2,496 | 5,224 |
| ROE (net income / shareholders' equity) | 5.91% | -2.02% | -2.59% | -2.73% | 0.08% | 3.68% |
| ROA (Net income/ Total Assets) | 2.53% | -0.39% | -0.77% | -0.62% | 0.64% | 2.17% |
| Assets 1 | 197,342 | 396,420 | 204,449 | 238,098 | 43,809 | 121,541 |
| Book Value Per Share 2 | 10,213 | 10,206 | 9,857 | 9,633 | 9,427 | 9,675 |
| Cash Flow per Share 2 | 283.0 | 200.0 | 1,251 | 323.0 | 478.0 | 829.0 |
| Capex 1 | 29,916 | 21,318 | 7,785 | 17,459 | 6,217 | 2,577 |
| Capex / Sales | 54.6% | 41.4% | 13.65% | 28.12% | 8.55% | 3.43% |
| Announcement Date | 07/03/19 | 06/03/20 | 24/02/21 | 10/03/22 | 22/03/23 | 11/03/24 |
1KRW in Million2KRW
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -5.88% | 38.42M | |
| +21.31% | 44.12B | |
| +23.60% | 22.71B | |
| +18.22% | 15.15B | |
| +12.82% | 13.61B | |
| +64.38% | 13.34B | |
| -8.27% | 6.84B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +15.65% | 5.63B |
- Stock Market
- Equities
- A200780 Stock
- Financials BCWORLD PHARM. Co., Ltd.
